Nexgel (NXGLW) Total Non-Current Liabilities (2018 - 2024)
Nexgel (NXGLW) reported Total Non-Current Liabilities of $4.7 million for Q4 2024, up 8.62% on a YoY basis from $4.4 million in Q1 2024, and down 11.1% quarter-over-quarter from $5.3 million in Q3 2024.
Nexgel (NXGLW) Total Non-Current Liabilities (2018 - 2024) Analysis & Trends
Nexgel has reported Total Non-Current Liabilities for 7 years, with the latest figure at $4.7 million in Q4 2024.
- For the quarter ending Q4 2024, Total Non-Current Liabilities rose 8.62% year-over-year to $4.7 million; the trailing twelve-month figure through Dec 2024 stood at $4.7 million (up 8.62% YoY), and the FY2024 full-year result was $4.7 million, up 8.62% from the prior year.
- Total Non-Current Liabilities for Q4 2024 stood at $4.7 million, down from $5.3 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $5.3 million in Q3 2024, with the low at $824000.0 in Q1 2021.
- Historically, Total Non-Current Liabilities has averaged $2.9 million across 5 years, with a median of $2.0 million in 2021.
- Annual changes were most pronounced in 2020 — Total Non-Current Liabilities sank 43.44% — and 2022, when it soared 139.32%.
- Nexgel's Total Non-Current Liabilities stood at $854000.0 in 2020, then jumped by 135.36% to $2.0 million in 2021, then declined by 5.42% to $1.9 million in 2022, then soared by 128.83% to $4.4 million in 2023, then grew by 8.62% to $4.7 million in 2024.
- The last three Total Non-Current Liabilities figures came in at $4.7 million (Q4 2024), $5.3 million (Q3 2024), and $4.9 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Nexgel | - | - | 819,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 4.88 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 4.35 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 2.01 Mn |
| Sep 30, 2021 | 2.05 Mn |
| Jun 30, 2021 | 2.07 Mn |
| Mar 31, 2021 | 824,000.00 |
| Dec 31, 2020 | 854,000.00 |
| Dec 31, 2019 | 1.51 Mn |
| Sep 30, 2019 | 1.44 Mn |
| Dec 31, 2018 | 407,000.00 |